We found that the efficacy of citarinostat on attenuating the HDAC6 deacetylase activity (Figure 2) and the induction of apoptosis (Figure 3) correspond directly to the reduced accumulation of citarinostat in ABCB1- and ABCG2-overexpressing human cancer cells (Figure 4). The gene discussed is ABCG2; the disease is cancer.